Reuters logo
4 months ago
BRIEF-Shire receives European approval for label extension of Cinryze
March 16, 2017 / 6:05 AM / 4 months ago

BRIEF-Shire receives European approval for label extension of Cinryze

1 Min Read

March 16 (Reuters) - Shire Plc

* Shire receives european approval for label extension of Cinryze(C1 inhibitor) to prevent and treat hereditary angioedema (HAE) attacks in paediatric patients with hae

* Cinryze is also now approved for treatment and pre-procedure prevention of Angioedema attacks in children (ages 2 years and above) with HAE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below